Clinical experience with cardiac amyloidosis

Acta Cardiologica

Volumn 58, Issue 2, 2003, Pages 143-147

  Goeminne, Ann ^a   Missault, Luc ^a   Bauwens, Frank ^b   De Pauw, Michel ^c   De Sutter, Johan ^c  

^a General Hospital St Jan   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c Algemeen Stedelijk Ziekenhuis   (Belgium)

Author keywords

Amyloidosis; Cardiomyopathy; Heart failure; Liver transplantation

Indexed keywords

AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; DEATH; DIAGNOSTIC IMAGING; DIASTOLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FAMILIAL AMYLOIDOSIS; FEMALE; HEART AMYLOIDOSIS; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART TRANSPLANTATION; HUMAN; LIVER TRANSPLANTATION; MALE; PROGNOSIS; RETROSPECTIVE STUDY; SYMPTOM; SYSTOLE;

ADULT; AGED; AMYLOIDOSIS; ELECTROCARDIOGRAPHY; ELECTROPHORESIS; FEMALE; HEART DISEASES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0037388341     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.58.2.2005267     Document Type: Article

References (18)

1. Falk RH, Comenzo R, Skinner M. Amyloidosis, review article. New Engl J Med 1997; 337: 898-907.
2. Gertz MA. Diagnosing primary amyloidosis. Editorial. Mayo Clin Proc 2002; 77: 1278-9.
3. Gertz M, Lacy M, Dispenzieri A. Amyloidosis: Recognition, confirmation, prognosis, and therapy. Mayo Clin Proc 1999; 74: 490-4.
4. Skinner MW, Lewis D, Jones LA, Kasirsky J, Kane K, Ju ST, Jenkins R, Falk RH, Simms RW, Cohen AS. Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Intern Med 1994; 120: 133-4.
5. Nihoyannopoulos P, Hawkins P. Hereditary cardiac amyloidosis. Eur Heart J 1998; 19: 686-8.
6. Kyle R. Amyloidosis. Circulation 1995; 91: 1269-70.
7. Schäfer S, Schardt C, Burkhard-Meier U, Michael Klein R, Heintzen M, E. Strauer B. Angina pectoris and progressive fatigue in a 61-year-old man. Circulation 1996; 94: 3376-81.
8. Oelke K, Aronoff D. A man with dyspnea and anasarca. Tenn Med 2000; 93: 28-9.
9. Ridofi RL, Buldley BH, Hutchins GM. The conduction system in cardiac amyloidosis. Am J Med 1977; 62: 677-86.
10. Reisinger J, Dubrey SW, Lavalley M, Skinner M. Falk RH. Electrophysiologic abnormalities in AL amyloidosis with cardiac involvement. JACC 1997; 30: 1046-51.
11. Borer JS, Henry WL, Epstein SE. Echocardiographic observations in patients with systemic infiltrative disease involving the heart. Am J Cardiol 1977; 39: 184-8.
12. Siqueira - Filho AG, Cunha CL, Tajik AJ, Seward JB, Schattenberg TT, Giuliani ER. M-mode and two dimensional echocardiographic features in cardiac amyloidosis. Circulation 1981; 63: 188-96.
13. Klein AL, Hatle LK, Burstow DJ, Taliercio CP, Seward JB, Kyle RA, Bailey KR, Gertz MA, Tajik AJ. Comprehensive Doppler assessment of right ventricular diastolic function in cardiac amyloidosis. JACC 1990; 15: 99-108.
14. Santarone M, Corrado G, Tagliagambe L, Foglia Manzillo G, Tadeo G, Spata M, Longhi M. Atrial thrombosis in cardiac amyloidosis: diagnostic contribution of transesophageal echocardiography. J Am Soc Echocardiography 1999; 12: 533-6.
15. Arbustine E, Meline G, Gavazzi A, Grasso M, Diegoli M, Fasani R, Bellotti V Morbini P, Dal Bello B. Cardiac immunocyte derived amyloidosis: an endomyocardial biopsy study in 11 patients. A. Heart J 1995; 130: 528-36.
16. Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB, Hawkins PN. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. New Engl J Med 2002; 346: 1786-91.
17. Grogan M, Gertz MA, Kyle RA, Tajik AJ. Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol 2000; 85: 664-5.
18. Pollak A, Falk RH. Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis. Chest 1993; 104: 618-20.